In an effort to probe the feasibility of a model of Mo-Cu CODH (CODH = carbon monoxide dehydrogenase) lacking a bridging sulfido group, the new heterodinucleating ligand LH 2 was designed and its Cu(I)/Mo(VI) reactivity was investigated. LH 2 ((E)-3-(((5-(bis(pyridin-2-ylmethyl)amino)-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)imino)methyl)benzene-1,2-diol) features two different chelating positions bridged by a xanthene linker: bis(pyridyl)amine for Cu(I) and catecholate for Mo(VI). LH 2 was synthesized via the initial protection of one of the amine positions, followed by two consecutive alkylations of the second position, deprotection, and condensation to attach the catechol functionality. LH 2 was found to exhibit dynamic cooperativity between two reactive sites mediated by H-bonding of the catechol protons. In the free ligand, catechol protons exhibit H-bonding with imine (intramolecular) and with pyridine (intermolecular in the solid state). The reaction of LH 2 with [Cu-(NCMe) 4 ] + led to the tetradentate coordination of Cu(I) via all nitrogen donors of the ligand, including the imine. Cu(I) complexes were characterized by multinuclear NMR spectroscopy, high-resolution mass spectrometry (HRMS), X-ray crystallography, and DFT calculations. Cu(I) coordination to the imine disrupted H-bonding and caused rotation away from the catechol arm. The reaction of the Cu(I) complex [Cu(LH 2 )] + with a variety of monodentate ligands X (PPh 3 , Cl − , SCN − , CN − ) released the metal from coordination to the imine, thereby restoring imine H-bonding with the catechol proton. The second catechol proton engages in H-bonding with Cu−X (X = Cl, CN, SCN), which can be intermolecular (XRD) or intramolecular (DFT). The reaction of LH 2 with molybdate [MoO 4 ] 2− led to incorporation of [Mo VI O 3 ] at the catecholate position, producing [MoO 3 (L)] 2− . Similarly, the reaction of [Cu(LH 2 )] + with [MoO 4 ] 2− formed the heterodinuclear complex [CuMoO 3 (L)] − . Both complexes were characterized by multinuclear NMR, UV−vis, and HRMS. HRMS in both cases confirmed the constitution of the complexes, containing molecular ions with the expected isotopic distribution.
In this study, we report the synthesis, characterization, and reactions of Cu(I) complexes of the general form Cu(L)(LigH2) (LigH2 = xanthene-based heterodinucleating ligand (E)-3-(((5-(bis(pyridin-2-ylmethyl)amino)-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)imino)methyl)benzene-1,2-diol); L = PMe3, PPh3, CN(2,6-Me2C6H3)). New complexes [Cu(PMe3)(LigH2)] and [CuCN(2,6-Me2C6H3)(LigH2)] were synthesized by treating [Cu(LigH2)](PF6) with trimethylphosphine and 2,6-dimethylphenyl isocyanide, respectively. These complexes were characterized by multinuclear NMR spectroscopy, IR spectroscopy, high-resolution mass spectrometry (HRMS), and X-ray crystallography. In contrast, attempted reactions of [Cu(LigH2)](PF6) with cyanide or styrene failed to produce isolable crystalline products. Next, the reactivity of these and previously synthesized Cu(I) phosphine and isocyanide complexes with molybdate was interrogated. IR (for isocyanide) and 31P NMR (for PPh3/PMe3) spectroscopy demonstrates the lack of oxidation reactivity. We also describe herein the first example of a structurally characterized multinuclear complex combining both Mo(VI) and Cu(I) metal ions within the same system. The heterobimetallic tetranuclear complex [Cu2Mo2O4(μ2-O)(Lig)2]·HOSiPh3 was obtained by the reaction of the silylated Mo(VI) precursor (Et4N)(MoO3(OSiPh3)) with LigH2, followed by the addition of [Cu(NCMe)4](PF6). This complex was characterized by NMR spectroscopy, high-resolution mass spectrometry, and X-ray crystallography.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.